December 12, 2014
Targeted Therapy Effective in Elderly Patients with Philadelphia-Positive Acute Lymphocytic Leukemia
While rates of remission among elderly patients with leukemia continue to improve, the outlook remains poor among those with a disease subtype present in nearly one-third […]
December 12, 2014
Recognizing that leukemia cannot be conquered with a “one-size-fits-all” approach, researchers are pursuing novel targeted therapies and combinations of existing treatment regimens with new agents for […]
December 12, 2014
The American Society of Hematology (ASH) is the world’s largest professional society of hematologists dedicated to furthering the understanding, treatment, and prevention of disorders affecting the […]
October 7, 2014
Cancer researchers have been almost giddy in the last couple of years about the potential of drugs like Keytruda, which seem to solve a century-old mystery […]
October 7, 2014
Could you discuss the KEYNOTE study results and the approval of pembrolizumab? Pembrolizumab was approved because it is active for the treatment of metastatic melanoma and […]
September 26, 2014
Last week, the FDA approved pembrolizumab (Keytruda) for the treatment of patients with advanced or unresectable melanoma following progression on prior therapies. In the pivotal KEYNOTE-001 […]
August 15, 2014
MHOA Monthly Newsletter No.1 Positivity in Adversity “Strength does not come from physical capacity. It comes from indomitable will.” -Mahatma Ghandi
August 1, 2014
[mc_carousel id=”carousel” carousel_images=”2770,2771,2772,2750,2773″ features_images_loop=”1″ lightbox_icon_color=”blue_light” autoplay=”0″ pause_on_hover=”1″ scroll=”1″ effect=”scroll” easing=”swing” duration=”500″ top_margin=”page_margin_top_section” el_position=”first last”] Thank You For Your Interest In Clinical Trials at MHOA Currently Enrolling […]
August 1, 2014
“I love the fact that today, with all the advances in diagnostics, drugs, and personalized cancer treatments, working with cancer patients is an exciting and optimistic […]
August 1, 2014
Brain Cancer New tumor-targeting agents (APC) able to seek out and find solid tumors, even illuminating brain cancer stem cells that resist current treatments Science Daily […]